These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 23153988)

  • 1. Fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) for the detection of skeletal muscle and skin metastases in uterine leiomyosarcoma: a case report.
    Ozdemir E; Poyraz NY; Uzun B; Türkölmez S
    Rev Esp Med Nucl Imagen Mol; 2013; 32(4):257-9. PubMed ID: 23153988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorine-18-fluorodeoxyglucose PET/CT for the evaluation of suspected recurrent uterine leiomyosarcomas.
    Kao YH; Saad U; Tan AE; Magsombol BM; Padhy AK
    Acta Radiol; 2011 May; 52(4):463-6. PubMed ID: 21498277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple leiomyosarcoma foci in 18F-FDG PET-CT.
    Sürücü E; Aslan M; Karahan P; Durak H
    Rev Esp Med Nucl Imagen Mol; 2013; 32(4):269-70. PubMed ID: 23122743
    [No Abstract]   [Full Text] [Related]  

  • 4. Fluorodeoxyglucose positron emission tomography/computed tomography and magnetic resonance imaging of uterine leiomyosarcomas: 2 cases report.
    Zhang HJ; Zhan FH; Li YJ; Sun HR; Bai RJ; Gao S
    Chin Med J (Engl); 2011 Jul; 124(14):2237-40. PubMed ID: 21933635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subcutaneous and intramuscular metastases of cervix cancer detected with ¹⁸F-fluoro-2-deoxyglucose positron emission tomography/computed tomography after the chemoradiation therapy.
    Tamam MO; Mulazimoglu M; Aydin T
    Rev Esp Med Nucl Imagen Mol; 2013 Mar; 32(2):128-9. PubMed ID: 23177331
    [No Abstract]   [Full Text] [Related]  

  • 6. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
    Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
    Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "One-stop-shop" staging: should we prefer FDG-PET/CT or MRI for the detection of bone metastases?
    Heusner T; Gölitz P; Hamami M; Eberhardt W; Esser S; Forsting M; Bockisch A; Antoch G
    Eur J Radiol; 2011 Jun; 78(3):430-5. PubMed ID: 19945240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The value of 18-FDG PET/CT imaging in a patient with atypical metastatic colorectal cancer--case report: 18-FDG PET/CT in colorectal cancer.
    Hlavatá Z; Pazderová N; Povinec P; Paulíny P; Majidi A; Fiala P; Martanovic P; Sálek T
    Klin Onkol; 2009; 22(6):284-7. PubMed ID: 20099747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supplemental value of diffusion-weighted whole-body imaging with background body signal suppression (DWIBS) technique to whole-body magnetic resonance imaging in detection of bone metastases from thyroid cancer.
    Sakurai Y; Kawai H; Iwano S; Ito S; Ogawa H; Naganawa S
    J Med Imaging Radiat Oncol; 2013 Jun; 57(3):297-305. PubMed ID: 23721138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intramuscular metastasis of uterine cervix cancer on F-18 FDG PET/CT.
    Hong IK; Kim DY
    Clin Nucl Med; 2011 Jun; 36(6):e39-41. PubMed ID: 21552014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PET-CT demonstration of extensive muscle metastases from breast cancer.
    Liu Y; Ghesani N; Mirani N; Zuckier LS
    Clin Nucl Med; 2006 May; 31(5):266-8. PubMed ID: 16622333
    [No Abstract]   [Full Text] [Related]  

  • 12. Schwannomatosis/neurofibromatosis type 2 associated multiple schwannomas visualized on FDG-PET/CT.
    Beylergil V; Haque S; Carver A; Bilsky MH; Carrasquillo JA
    Rev Esp Med Nucl Imagen Mol; 2013; 32(4):275-6. PubMed ID: 23582492
    [No Abstract]   [Full Text] [Related]  

  • 13. Malignant skin and subcutaneous neoplasms in adults: multimodality imaging with CT, MRI, and 18F-FDG PET/CT.
    Juan YH; Saboo SS; Tirumani SH; Khandelwal A; Shinagare AB; Ramaiya N; Krajewski KM
    AJR Am J Roentgenol; 2014 May; 202(5):W422-38. PubMed ID: 24758677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of age-related changes in structure and function of skin, adipose tissue, and skeletal muscle with computed tomography, magnetic resonance imaging, and positron emission tomography.
    Wehrli NE; Bural G; Houseni M; Alkhawaldeh K; Alavi A; Torigian DA
    Semin Nucl Med; 2007 May; 37(3):195-205. PubMed ID: 17418152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolated facial muscle metastasis from renal cell carcinoma on F-18 FDG PET/CT.
    Kang S; Song BI; Lee HJ; Jeong SY; Seo JH; Lee SW; Ahn BC; Lee J; Lee HJ
    Clin Nucl Med; 2010 Apr; 35(4):263-4. PubMed ID: 20305417
    [No Abstract]   [Full Text] [Related]  

  • 16. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.
    Roh JL; Yeo NK; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scanning with 18F-FDG-PET/CT for detection of pelvic nodal involvement in inguinal node-positive penile carcinoma.
    Graafland NM; Leijte JA; Valdés Olmos RA; Hoefnagel CA; Teertstra HJ; Horenblas S
    Eur Urol; 2009 Aug; 56(2):339-45. PubMed ID: 19477581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent and metastatic breast cancer PET, PET/CT, PET/MRI: FDG and new biomarkers.
    Gaeta CM; Vercher-Conejero JL; Sher AC; Kohan A; Rubbert C; Avril N
    Q J Nucl Med Mol Imaging; 2013 Dec; 57(4):352-66. PubMed ID: 24322792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of clinical stage III melanoma patients with FDG-PET and whole-body CT added to the diagnostic workup.
    Niebling MG; Bastiaannet E; Hoekstra OS; Bonenkamp JJ; Koelemij R; Hoekstra HJ
    Ann Surg Oncol; 2013 Sep; 20(9):3098-105. PubMed ID: 23612885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated FDG-PET-CT: its role in the assessment of bone and soft tissue tumors.
    Bischoff M; Bischoff G; Buck A; von Baer A; Pauls S; Scheffold F; Schultheiss M; Gebhard F; Reske SN
    Arch Orthop Trauma Surg; 2010 Jul; 130(7):819-27. PubMed ID: 19636577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.